Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$22.97 - $30.58 $191,248 - $254,609
8,326 New
8,326 $227,000
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $514,295 - $818,854
17,024 New
17,024 $566,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.43B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Rwc Asset Management LLP Portfolio

Follow Rwc Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rwc Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rwc Asset Management LLP with notifications on news.